甲托雷克萨特相关的B细胞淋巴增殖性疾病,由于尿膀病变而表现出血:一个病例报告
相关实验视频
Updated: May 2, 2026

09:07
An Orthotopic Model of Murine Bladder Cancer
Published on: February 6, 2011
15.9K
Masahiro Manabe1, Yuki Nagano2, Takahiro Okuno3
1Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka 545-0053, Japan.
Medicine international
|June 24, 2024
概括
与甲基 (MTX) 相关的淋巴增殖性疾病 (LPD) 是一种罕见的并发症. 这一案例突显了MTX-LPD呈现为尿膀质量,强调了在MTX治疗期间需要保持警.
科学领域:
- 在瘤学瘤学.
- 类风湿病学 类风湿病学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 甲甲酸 (MTX) 是一种广泛用于治疗自身免疫性疾病的免疫抑制药物.
- 与MTX相关的淋巴增殖性疾病 (LPD) 是一种已知的,尽管不常见的,MTX治疗的晚期并发症.
- 额外的参与是MTX-LPD的特征,但膀参与是非常罕见的.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Kidney Transplant II: Surgical Procedure
926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926

